Diabetes
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
|
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) |
HHS-NIH11 |
08/24/2023 |
01/07/2027 |
|
|
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) |
HHS-NIH11 |
08/23/2023 |
01/07/2027 |
|
|
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
HHS-NIH11 |
09/12/2022 |
09/07/2025 |
|
|
Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional) |
HHS-NIH11 |
12/01/2021 |
05/07/2025 |